Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research

HOUSTON, Sept. 16 /PRNewswire/ -- Ascendant Neuro is pleased to announce the addition of Kenneth Alo, M.D., an internationally recognized specialist who has joined to further the advancement of the group's minimally invasive pain treatment techniques through the innovative use of neurostimulators. Dr. Alo will serve as Director of Neuromodulation and Clinical Research.  

Dr. Alo graduated from Texas A&M University College of Medicine and completed his General Surgery Internship, Anesthesiology Residency, and Interventional Pain Fellowship at The Methodist Hospital, and Baylor College of Medicine Affiliated Hospitals in the Texas Medical Center.  He is board certified and has been active in supporting the American Academy of Pain Medicine, the American Neuromodulation Society, the National Pain Foundation, the International Neuromodulation Society, The International Association for the Study of Pain, The American Pain Foundation, and the American Pain Society in various roles.

In addition to serving on the Editorial Board of "Neuromodulation – Journal of Technology at the Neural Interface," Dr. Alo's research has been published in "The Journal Neurosurgery," "Proceedings of the International Neuromodulation Society," "The International Journal the Pain Clinic," "Neuromodulation – Journal of Technology at the Neural Interface," "Neurocontact," "The Journal Headache and Facial Pain," and "Pain Practice," among others.  On behalf of physicians and patients in the United States and abroad, Dr. Alo is regularly asked to lecture and demonstrate the latest diagnostic and therapeutic practices.  Dr. Alo has conducted or participated in programs including workshops, clinical trials, presentations and meetings, as well as visiting professorships (University of Basel, University of Vienna and the University of Pisa) since beginning practice in 1994.  He remains active as the Director of the Section of Neuro-Cardiology at the Institute of Cardiology and Vascular Medicine – Monterrey Technical University, and is participating in clinical research at the Methodist Hospital Research Institute in the Texas Medical Center.

"We are extremely pleased to have Dr. Alo join Ascendant Neuro and our specially trained physicians," said Alex Noffsinger, President of Ascendant Neuro. "Dr. Alo's clinical knowledge and experience will help more chronic-pain patients live the pain-free lives they deserve."

Ascendant Neuro is able to treat all type of severe headaches, including any kind of severe head pain that occurs on a consistent and frequent basis. Even patients with the most severe chronic migraine headaches who have not responded to other treatments commonly respond dramatically to this type of treatment – often with virtually complete resolution of the headaches during the use of the stimulator.

Ascendant Neuro plans to expand its elite group of hand-selected specialists in key locations nationwide, including the recently opened Houston location, as well as Southern California and New Jersey, with expansion to select markets internationally also under way.

For more information about Dr. Alo and Ascendant Neuro's neurostimulation treatments, please visit www.ascendantneuro.com.

About Ascendant Neuro

For the past 15 years, Ascendant Neuro has successfully conducted minimally invasive pain treatment techniques through the innovative use of neurostimulators. Ascendant Neuro's trained physicians, who treat chronic pain of the spine as well as chronic migraine headaches, use neurostimulation to eliminate the symptoms of migraine and chronic head pain.

Ascendant Neuro currently operates at Forest Park Medical Center in Dallas, Texas, and University General Hospital in Houston, Texas. For more information, please visit www.ascendantneuro.com.

SOURCE Ascendant Neuro